INmune Bio Correlations

INMB Stock

USD 4.90 0.03 0.62%

The current 90-days correlation between INmune Bio and Cue Biopharma is 0.23 (i.e., Modest diversification). The correlation of INmune Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

INmune Bio Correlation With Market

Weak diversification

The correlation between INmune Bio and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INmune Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.

Moving together with INmune Stock

0.61

DAIUF

Daifuku

Pair Corr

Moving against INmune Stock

0.48	FMCB	Farmers Merchants Bancorp	Pair Corr
0.47	FUWAF	Furukawa Electric	Pair Corr
0.42	INFU	InfuSystems Holdings	Pair Corr
0.67	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.6	HD	Home Depot	Pair Corr
0.57	VZ	Verizon Communications Fiscal Year End 28th of January 2025	Pair Corr
0.55	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.49	DIS	Walt Disney	Pair Corr
0.41	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.4	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.4	PG	Procter Gamble	Pair Corr
0.34	HPQ	HP Inc	Pair Corr
0.34	T	ATT Inc Aggressive Push	Pair Corr
0.33	MCD	McDonalds Sell-off Trend	Pair Corr

Related Correlations Analysis

	TFFP	ANEB	ABCM	ANTX	CUE	ANIX	INAB	PYPD	AVTE	ELYM
TFFP		0.72	-0.77	-0.74	-0.03	0.19	-0.17	0.2	-0.64	0.64	TFFP
ANEB	0.72		-0.7	-0.55	-0.4	0.15	-0.14	0.25	-0.71	0.76	ANEB
ABCM	-0.77	-0.7		0.58	0.41	0.12	0.2	-0.23	0.88	-0.76	ABCM
ANTX	-0.74	-0.55	0.58		0.09	0.05	0.07	-0.45	0.52	-0.54	ANTX
CUE	-0.03	-0.4	0.41	0.09		0.23	-0.05	-0.2	0.63	-0.73	CUE
ANIX	0.19	0.15	0.12	0.05	0.23		0.24	-0.09	0.1	0.02	ANIX
INAB	-0.17	-0.14	0.2	0.07	-0.05	0.24		-0.07	0.06	0.02	INAB
PYPD	0.2	0.25	-0.23	-0.45	-0.2	-0.09	-0.07		-0.28	0.32	PYPD
AVTE	-0.64	-0.71	0.88	0.52	0.63	0.1	0.06	-0.28		-0.87	AVTE
ELYM	0.64	0.76	-0.76	-0.54	-0.73	0.02	0.02	0.32	-0.87		ELYM
	TFFP	ANEB	ABCM	ANTX	CUE	ANIX	INAB	PYPD	AVTE	ELYM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AVTE	+ 0.88	ABCM
ELYM	+ 0.76	ANEB
ANEB	+ 0.72	TFFP
ELYM	+ 0.64	TFFP
AVTE	+ 0.63	CUE
ANTX	+ 0.58	ABCM

High negative correlations

ELYM	- 0.87	AVTE
ABCM	- 0.77	TFFP
ELYM	- 0.76	ABCM
ANTX	- 0.74	TFFP
ELYM	- 0.73	CUE
AVTE	- 0.71	ANEB

Risk-Adjusted Indicators

There is a big difference between INmune Stock performing well and INmune Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze INmune Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TFFP	6.82	(1.56)	0.00	(1.23)	0.00	0.00	11.28	(12.99)	95.77
ANEB	4.88	(0.23)	0.00	(0.06)	0.00	0.00	8.61	(11.48)	76.00
ABCM	2.25	0.52	0.24	0.59	1.76	(2.90)	6.14	(3.03)	24.49
ANTX	2.30	0.47	0.17	0.58	1.83	(3.91)	6.00	(4.19)	28.89
CUE	7.70	1.23	0.17	2.88	5.98	(11.87)	20.27	(11.51)	67.78
ANIX	2.63	(0.13)	0.00	(0.06)	0.00	0.00	4.93	(5.74)	31.27
INAB	5.92	(0.46)	0.00	(0.04)	0.00	0.00	17.39	(11.76)	109.03
PYPD	2.59	(0.34)	0.00	(0.18)	0.00	0.00	4.66	(7.90)	23.57
AVTE	2.35	0.40	0.15	0.65	2.03	(3.18)	5.58	(3.86)	19.11
ELYM	3.90	(0.88)	0.00	(3.05)	0.00	0.00	6.21	(9.35)	34.87

INmune Bio Corporate Management

Christopher Barnum	Head Neuroscience	Profile
BSc FRCPath	Chief Officer	Profile
Raymond MD	President, CoFounder	Profile
Joshua Esq	General Counsel	Profile
David MBA	Treasurer CFO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC